|
Volumn 3, Issue 6, 2002, Pages 643-656
|
Somatostatin analogues in the treatment of endocrine tumours of the gastrointestinal tract
a a a |
Author keywords
Antiproliferative therapy; Carcinoids; IFN ; Neuroendocrine tumours; Somatostatin analogues; Symptomatic therapy
|
Indexed keywords
ALPHA INTERFERON;
AMINO ACID;
ANGIOPEPTIN;
ANTINEOPLASTIC AGENT;
CHELATING AGENT;
CISPLATIN;
DACARBAZINE;
ETOPOSIDE;
INDIUM 111;
LONG ACTING DRUG;
LUTETIUM;
OCTREOTIDE;
PLACEBO;
RECEPTOR SUBTYPE;
SOMATOSTATIN;
SOMATOSTATIN DERIVATIVE;
SOMATOSTATIN RECEPTOR;
STREPTOZOCIN;
YTTRIUM 90;
CYCLOPEPTIDE;
DRUG DERIVATIVE;
RADIOISOTOPE;
ABDOMINAL PAIN;
ALOPECIA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
AUTONOMIC DYSFUNCTION;
CANCER INHIBITION;
CARCINOID;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG BINDING;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG POTENCY;
DRUG SAFETY;
DRUG STRUCTURE;
ENDOCRINE TUMOR;
FLATULENCE;
GALLSTONE FORMATION;
GASTROINTESTINAL TUMOR;
GLUCAGONOMA;
HEMATOLOGIC DISEASE;
HORMONE RELEASE;
HUMAN;
HYPERGLYCEMIA;
INSULINOMA;
METASTASIS;
NAUSEA;
NEPHROTOXICITY;
NONHUMAN;
OBSTRUCTIVE JAUNDICE;
PAIN;
RASH;
REVIEW;
STEATORRHEA;
SYMPTOMATOLOGY;
VERNER MORRISON SYNDROME;
VOMITING;
WATER INTOXICATION;
ANIMAL;
DRUG COMBINATION;
DRUG EFFECT;
METABOLISM;
NEOPLASM;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
DRUG THERAPY, COMBINATION;
GASTROINTESTINAL NEOPLASMS;
HUMANS;
INTERFERON-ALPHA;
NEOPLASMS, GLANDULAR AND EPITHELIAL;
OCTREOTIDE;
PEPTIDES, CYCLIC;
RADIOISOTOPES;
RECEPTORS, SOMATOSTATIN;
SOMATOSTATIN;
|
EID: 0036076626
PISSN: 14656566
EISSN: None
Source Type: Journal
DOI: 10.1517/14656566.3.6.643 Document Type: Review |
Times cited : (54)
|
References (134)
|